BlackRock’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $365M | Buy |
7,680,073
+171,895
| +2% | +$9.07M | 0.01% | 1313 |
|
|
2025
Q4 | $394M | Buy |
7,508,178
+458,033
| +6% | +$27.4M | 0.01% | 1263 |
|
|
2025
Q3 | $457M | Buy |
7,050,145
+983,787
| +16% | +$56.5M | 0.01% | 1156 |
|
|
2025
Q2 | $295M | Buy |
6,066,358
+3,452,819
| +132% | +$134M | 0.01% | 1379 |
|
|
2025
Q1 | $88.9M | Sell |
2,613,539
-145,787
| -5% | -$6.18M | ﹤0.01% | 2065 |
|
|
2024
Q4 | $109M | Sell |
2,759,326
-35,973
| -1% | -$1.7M | ﹤0.01% | 2038 |
|
|
2024
Q3 | $131M | Buy |
2,795,299
+17,515
| +0.6% | +$889K | ﹤0.01% | 1925 |
|
|
2024
Q2 | $150M | Buy |
2,777,784
+231,423
| +9% | +$13.4M | ﹤0.01% | 1786 |
|
|
2024
Q1 | $174M | Buy |
2,546,361
+29,875
| +1% | +$2.14M | ﹤0.01% | 1738 |
|
|
2023
Q4 | $158M | Sell |
2,516,486
-196,724
| -7% | -$10.9M | ﹤0.01% | 1809 |
|
|
2023
Q3 | $123M | Sell |
2,713,210
-5,365
| -0.2% | -$277K | ﹤0.01% | 1870 |
|
|
2023
Q2 | $153M | Sell |
2,718,575
-80,006
| -3% | -$4.54M | ﹤0.01% | 1777 |
|
|
2023
Q1 | $127M | Buy |
2,798,581
+168,844
| +6% | +$8.2M | ﹤0.01% | 1865 |
|
|
2022
Q4 | $107M | Buy |
2,629,737
+283,153
| +12% | +$15M | ﹤0.01% | 1945 |
|
|
2022
Q3 | $153M | Buy |
2,346,584
+194,458
| +9% | +$14.1M | 0.01% | 1672 |
|
|
2022
Q2 | $131M | Sell |
2,152,126
-126,648
| -6% | -$7.45M | ﹤0.01% | 1852 |
|
|
2022
Q1 | $143M | Buy |
2,278,774
+1,007,246
| +79% | +$63.2M | ﹤0.01% | 1896 |
|
|
2021
Q4 | $96.4M | Buy |
1,271,528
+142,244
| +13% | +$12.4M | ﹤0.01% | 2240 |
|
|
2021
Q3 | $126M | Buy |
1,129,284
+78,736
| +7% | +$9.89M | ﹤0.01% | 2068 |
|
|
2021
Q2 | $170M | Sell |
1,050,548
-239,787
| -19% | -$29.2M | ﹤0.01% | 1892 |
|
|
2021
Q1 | $157M | Buy |
1,290,335
+117,076
| +10% | +$17.7M | ﹤0.01% | 1889 |
|
|
2020
Q4 | $180M | Buy |
1,173,259
+19,416
| +2% | +$2.29M | 0.01% | 1702 |
|
|
2020
Q3 | $96.5M | Buy |
1,153,843
+141,026
| +14% | +$12.5M | ﹤0.01% | 1904 |
|
|
2020
Q2 | $74.4M | Buy |
1,012,817
+399,288
| +65% | +$23.3M | ﹤0.01% | 2026 |
|
|
2020
Q1 | $26M | Sell |
613,529
-15,028
| -2% | -$776K | ﹤0.01% | 2466 |
|
|
2019
Q4 | $38.3M | Buy |
628,557
+12,827
| +2% | +$700K | ﹤0.01% | 2522 |
|
|
2019
Q3 | $25.2M | Buy |
615,730
+20,397
| +3% | +$975K | ﹤0.01% | 2683 |
|
|
2019
Q2 | $28M | Sell |
595,333
-5,148
| -0.9% | -$206K | ﹤0.01% | 2664 |
|
|
2019
Q1 | $21.4M | Sell |
600,481
-38,754
| -6% | -$1.34M | ﹤0.01% | 2712 |
|
|
2018
Q4 | $18.3M | Sell |
639,235
-70,408
| -10% | -$2.45M | ﹤0.01% | 2768 |
|
|
2018
Q3 | $31.5M | Buy |
709,643
+116,116
| +20% | +$6.08M | ﹤0.01% | 2631 |
|
|
2018
Q2 | $34.9M | Buy |
593,527
+21,309
| +4% | +$1.21M | ﹤0.01% | 2559 |
|
|
2018
Q1 | $26.2M | Buy |
572,218
+19,660
| +4% | +$811K | ﹤0.01% | 2620 |
|
|
2017
Q4 | $13M | Buy |
552,558
+549,254
| +16,624% | +$10.4M | ﹤0.01% | 3015 |
|
|
2017
Q3 | $59K | Buy |
+3,304
| New | +$59.9K | ﹤0.01% | 4451 |
|
Other funds holding CRSP
AIM
OAG
GP
SOCM
NAMA